The Current Ratio as of November 2024 (TTM) for Jasper Therapeutics, Inc. (JSPR) is 7.61

According to Jasper Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.61. This represents a change of -22.12% compared to the average of 9.77 of the last 4 quarters.

Jasper Therapeutics, Inc. (JSPR) Historical Current Ratio (quarterly & annually)

How has JSPR Current Ratio performed in the past?

The mean historical Current Ratio of Jasper Therapeutics, Inc. over the last ten years is 8.57. The current 7.61 Current Ratio has changed 8.78% with respect to the historical average. Over the past ten years (40 quarters), JSPR's Current Ratio was at its highest in in the March 2020 quarter at 243.91. The Current Ratio was at its lowest in in the December 2019 quarter at 0.

Jasper Therapeutics, Inc. (JSPR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Jasper Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jasper Therapeutics, Inc. (JSPR) Average Current Ratio

How has JSPR Current Ratio performed in the past?

The current Current Ratio of Jasper Therapeutics, Inc. (JSPR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jasper Therapeutics, Inc. (JSPR) Current Ratio vs. Peers

How is JSPR’s Current Ratio compared to its peers?

Jasper Therapeutics, Inc.’s Current Ratio is greater than Lyra Therapeutics, Inc. (3.64), greater than Equillium, Inc. (3.04), greater than HOOKIPA Pharma Inc. (3.26), less than LianBio (10.06), less than Acumen Pharmaceuticals, Inc. (10.43), greater than Galera Therapeutics, Inc. (5.63), less than Inozyme Pharma, Inc. (7.68), greater than Eledon Pharmaceuticals, Inc. (6.53), less than Icosavax, Inc. (18.06), less than Edgewise Therapeutics, Inc. (26.35), less than Ikena Oncology, Inc. (15.32), less than Design Therapeutics, Inc. (34.61), greater than Xilio Therapeutics, Inc. (1.67), less than Eliem Therapeutics, Inc. (60.41), less than POINT Biopharma Global Inc. (0), less than ORIC Pharmaceuticals, Inc. (9.14), less than Inhibrx Biosciences, Inc. (13.15), greater than ESSA Pharma Inc. (4.70), less than null (36.95),

Build a custom stock screener for Jasper Therapeutics, Inc. (JSPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jasper Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jasper Therapeutics, Inc. (JSPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jasper Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.